Brief: Lipocine Announces Financial Results For Q1 Ended March 31, 2023
May 11 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER
ENDED
MARCH 31, 2023
* LIPOCINE INC Q1 LOSS PER SHARE $0.04
* LIPOCINE INC - AS OF MARCH 31, HAD $28.9 MILLION
UNRESTRICTED
CASH, CASH EQUIVALENTS, MARKETABLE INVESTMENT SECURITIES VERSUS.
$32.5 MILLION AT DEC 31, 2022
Source text for Eikon: ID:nPn6Nq6qVa
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy